Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Modulation of transcription, either synthetic activation or repression, via dCas9-fusion proteins is a relatively new methodology with the potential to facilitate high-throughput up- or downregulation studies of gene function. Genetic studies of neurodevelopmental disorders have identified a growing list of risk variants, including both common single-nucleotide variants and rare copy-number variations, many of which are associated with genes having limited functional annotations. By applying a CRISPR-mediated gene-activation/repression platform to populations of human-induced pluripotent stem cell-derived neural progenitor cells, neurons, and astrocytes, we demonstrate that it is possible to manipulate endogenous expression levels of candidate neuropsychiatric risk genes across these three cell types. Although proof-of-concept studies using catalytically inactive Cas9-fusion proteins to modulate transcription have been reported, here we present a detailed survey of the reproducibility of gRNA positional effects across a variety of neurodevelopmental disorder-relevant risk genes, donors, neural cell types, and dCas9 effectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 2×
“…the catalytically inactive or dead Cas9 (dCas9) to a variety of effector protein domains, the modulation of transcription (Gilbert et al., 2013; Qi et al., 2013), DNA methylation (McDonald et al., 2016; Vojta et al., 2016), and histone modifications (Hilton et al., 2015) have all been…”
BackgroundOptimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 1×
“Despite advances in gRNA design algorithms (Chari et al., 2015; Doench et al., 2014, 2016; Xu et al., 2015), gRNA efficacy across individuals, cell types, and dCas9 effectors still must be empirically confirmed.”
MethodCRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 2×
“By simultaneously introducing nuclease-null mutations into Cas9 (Gilbert et al., 2013; Qi et al., 2013), and coupling the catalytically inactive or dead Cas9 (dCas9) to a variety of effector protein domains, the modulation of transcription (Gilbert et al., 2013; Qi et al., 2013), DNA methylation…”
BackgroundGenome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 1×
“Several groups have successfully applied the CRISPRdCas9 system to modulate gene expression levels for large-scale genome-wide screens (Carlson-Stevermer et al., 2016; Gilbert et al., 2014; Horlbeck et al., 2016a; Konermann et al., 2015).”
MethodGenome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728 · cited 1×
“Several groups have successfully applied the CRISPRdCas9 system to modulate gene expression levels for large-scale genome-wide screens (Carlson-Stevermer et al., 2016; Gilbert et al., 2014; Horlbeck et al., 2016a; Konermann et al., 2015).”
MethodZhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295 · cited 1×
“Third, highly expressed in neurons (Zhang et al., 2016), SNAP91 and CLCN3 transcriptional modulation was tested in NEUROGENIN2 (NGN2)-induced populations of excitatory neurons (Ho et al., 2016; Zhang et al., 2013) after 8 days of maturation.”
Dixit, A., Parnas, O., Li, B., Chen, J., Fulco, C. P., Jerby-Arnon, L., Marjanovic, N. D., Dionne, D., Burks, T., Raychowdhury, R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.038 · Cited by 1,863 · cited 1×
“…our FACS (Figure S2A) and qPCR (Figures S2B and S2C) data suggest that the difference in dCas9 expression across individuals is small, an observation that is consistent with findings that dCas9 KRAB expression does not correlate to the level of changes gene expression achieved (Dixit et al., 2016).”
ResultRapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 1×
“Third, highly expressed in neurons (Zhang et al., 2016), SNAP91 and CLCN3 transcriptional modulation was tested in NEUROGENIN2 (NGN2)-induced populations of excitatory neurons (Ho et al., 2016; Zhang et al., 2013) after 8 days of maturation.”
BackgroundHighly efficient Cas9-mediated transcriptional programming
Chavez, A., Scheiman, J., Vora, S., Pruitt, B. W., Tuttle, M., P R Iyer, E., Lin, S., Kiani, S., Guzman, C. D., Wiegand, D. J., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3312 · Cited by 1,622
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation
Doench, J. G., Hartenian, E., Graham, D. B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B. L., Xavier, R. J., & Root, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.3026 · Cited by 1,617
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · cited 3×
“…demonstrated aberrant gene expression, protein levels and migration in SZ hiPSC-derived neural progenitor cells (NPCs) (Brennand et al., 2015; Topol et al., 2015, 2016), and diminished neuronal connectivity and synaptic activity in SZ hiPSC-derived neurons (Brennand et al., 2011; Yu et al., 2014).”
BackgroundSelf-citationEditing DNA Methylation in the Mammalian Genome
Liu, X. S., Wu, H., Ji, X., Stelzer, Y., Wu, X., Czauderna, S., Shu, J., Dadon, D., Young, R. A., & Jaenisch, R. (2016) · Cell · doi:10.1016/j.cell.2016.08.056 · Cited by 1,224 · cited 11×
“We recommend validating gRNA efficacy across not just each individual hiPSC line to be evaluated, but also each dCas9 effector to be employed. dCas9 VP64 Transcript Induction Efficacies Are Not Necessarily Consistent between NPCs, Neurons, Astrocytes, and HEK293T Cells Given that chromatin states, particularly nucleos…”
BackgroundInfluentialContribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
Marshall, C. R., Howrigan, D. P., Merico, D., Thiruvahindrapuram, B., Wu, W., Greer, D. S., Antaki, D., Shetty, A., Holmans, P. A., Pinto, D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3725 · Cited by 1,058
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012 · cited 2×
“…Stem Cell Reports j Vol. 9 j 615–628 j August 8, 2017 (downregulation using a dCas9 fusion to the Krüppelassociated box [KRAB] repressor domain [Thakore et al., 2015]; upregulation using a dCas9 fusion to the tetrameric VP16 transcription activator domain [VP64] [Kearns et al., 2014; Maeder…”
MethodGenome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944 · cited 1×
“There is substantial evidence that the epigenetic landscape impacts gRNA efficacies, including chromatin structure (Chari et al., 2015; Knight et al., 2015; Singh et al., 2015;Wu et al., 2014), nucleosome positioning (Horlbeck et al., 2016b), and DNAmethylation (Wu et al., 2014).”
BackgroundHorlbeck, M. A., Gilbert, L. A., Villalta, J. E., Adamson, B., Pak, R. A., Chen, Y., Fields, A. P., Park, C. Y., Corn, J. E., Kampmann, M., et al. (2016) · eLife · doi:10.7554/elife.19760 · Cited by 894
Sequence determinants of improved CRISPR sgRNA design
Xu, H., Xiao, T., Chen, C.-H., Li, W., Meyer, C. A., Wu, Q., Wu, D., Cong, L., Zhang, F., Liu, J. S., et al. (2015) · Genome Research · doi:10.1101/gr.191452.115 · Cited by 625
Synaptic dysregulation in a human iPS cell model of mental disorders
Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., et al. (2014) · Nature · doi:10.1038/nature13716 · Cited by 549
An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells
TCW, J., Wang, M., Pimenova, A. A., Bowles, K. R., Hartley, B. J., Lacin, E., Machlovi, S. I., Abdelaal, R., Karch, C. M., Phatnani, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.018 · Cited by 435 · cited 2×
“…of hiPSC-astrocytes that shares the transcriptional profile and functional characteristics of human fetal astrocytes via a 30-day protocol (TCW et al., 2017). qPCR characterization of hiPSC-derived NPCs, neurons, NGN2 neurons, and astrocytes demonstrated baseline expression of all five…”
BackgroundSelf-citationGenetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004432 · Cited by 294 · cited 1×
“As extensive transcriptional variability exists between hiPSCs from different donors (Carcamo-Orive et al., 2017; Nishizawa et al., 2016; Rouhani et al., 2014), we first considered how well the activating capabilities of both platforms translated across five genes (Figure 1C) using neural cells…”
BackgroundYoon, K.-J., Nguyen, H. N., Ursini, G., Zhang, F., Kim, N.-S., Wen, Z., Makri, G., Nauen, D., Shin, J. H., Park, Y., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.05.003 · Cited by 240 · cited 1×
“…2010) findings, the precise functional dissection of SZ ‘‘risk genes’’ in hiPSC neuronal models has been challenging, except for small studies of rare families with SZ-associated inherited mutations (Lin et al., 2016; Srikanth et al., 2015; Wen et al., 2014; Yoon et al., 2014; Zhao et al., 2015).”
Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
Isaac, R. S., Jiang, F., Doudna, J. A., Lim, W. A., Narlikar, G. J., & Almeida, R. (2016) · eLife · doi:10.7554/elife.13450 · Cited by 234 · cited 1×
“…particularly nucleosome positioning, can differ between cell types (Jiang and Pugh, 2009) and that nucleosomes can impede Cas9 access to DNA (Horlbeck et al., 2016b; Isaac et al., 2016), we next set out to determine whether gRNA activity in NPCs or neurons is predictive of efficacy in astrocytes.”
BackgroundThe 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity
16p11.2 European Consortium, Maillard, A. M., Ruef, A., Pizzagalli, F., Migliavacca, E., Hippolyte, L., Adaszewski, S., Dukart, J., Ferrari, C., Conus, P., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.145 · Cited by 217 · cited 1×
“…disorders (CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium; Psychosis Endophenotypes International Consortium, 2017; Maillard et al., 2015), whereas synaptosome-associated protein 91 (SNAP91) and chloride voltage-gated channel 3 (CLCN3) have both recently been…”
BackgroundCas9-chromatin binding information enables more accurate CRISPR off-target prediction
Singh, R., Kuscu, C., Quinlan, A., Qi, Y., & Adli, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv575 · Cited by 217
Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells
Topol, A., Zhu, S., Hartley, B. J., English, J., Hauberg, M. E., Tran, N., Rittenhouse, C. A., Simone, A., Ruderfer, D. M., Johnson, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.090 · Cited by 122
Self-citation
Cited by
CRISPR/Cas9-based engineering of the epigenome
Pulecio, J., Verma, N., Mejía-Ramírez, E., Huangfu, D., & Raya, A. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.09.006 · Cited by 300
Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk
Rajarajan, P., Borrman, T., Liao, W., Schrode, N., Flaherty, E., Casiño, C., Powell, S., Yashaswini, C., LaMarca, E. A., Kassim, B., et al. (2018) · Science · doi:10.1126/science.aat4311 · Cited by 219
Self-citationWang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.002 · Cited by 185
Self-citationPICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia
Kozlova, A., Zhang, S., Sudwarts, A., Zhang, H., Smirnou, S., Byeon, S. K., Thapa, C., Sun, X., Stephenson, K., Zhao, X., et al. (2025) · Nature · doi:10.1038/s41586-025-09486-x · Cited by 69
rs953413 Regulates Polyunsaturated Fatty Acid Metabolism by Modulating ELOVL2 Expression
Pan, G., Cavalli, M., Carlsson, B., Skrtic, S., Kumar, C., & Wadelius, C. (2020) · iScience · doi:10.1016/j.isci.2019.100808 · Cited by 26
“Transactivation and transrepression of the rs953413 locus through dCas9-effector coupled with rs953413 AS-gRNA Lentiviral plasmid lenti-EF1a-dCas9-KRAB-Puro (Addgene plasmid # 99372), lenti-EF1a-dCas9-VP64- Puro (Addgene plasmid # 99371) and lentiGuide-Hygro-eGFP (Addgene plasmid # 99375) were gifts from Kristen Brenn…”
BackgroundInfluential
Metadata
- Authors
- Ho, S.-M., Hartley, B. J., Flaherty, E., Rajarajan, P., Abdelaal, R., Obiorah, I., Barretto, N., Muhammad, H., Phatnani, H. P., Akbarian, S., & Brennand, K. J.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 9
- Issue
- 2
- Pages
- 615-628
- ISSN
- 2213-6711 (ISSN-L)
- OpenAlex
- W2741244157
- Cited by
- 84
- References
- 25
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.